-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gdwt8dAwHG9DGpKa49i3XlyGcQceNP5AtkdDATiJ8fteSOkp71VkQnRwNIQbaaxQ C6nqnGrrKStomS7QuELnzQ== 0001098026-03-000003.txt : 20030509 0001098026-03-000003.hdr.sgml : 20030509 20030509111545 ACCESSION NUMBER: 0001098026-03-000003 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030509 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GTC BIOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000904973 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043186494 STATE OF INCORPORATION: MA FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44314 FILM NUMBER: 03689381 BUSINESS ADDRESS: STREET 1: 175 CROSSING BLVD CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508620-970 MAIL ADDRESS: STREET 1: 175 CROSSING BLVD CITY: FRAMINGHAM STATE: MA ZIP: 01701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: INTRINSIC VALUE ASSET MANAGEMENT INC CENTRAL INDEX KEY: 0001098026 IRS NUMBER: 954779707 STATE OF INCORPORATION: CA FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 29229 HEATHERCLIFF ROAD CITY: MALIBU STATE: CA ZIP: 90265 BUSINESS PHONE: 3104579303 MAIL ADDRESS: STREET 1: 29229 HEATHERCLIFF ROAD CITY: MALIBU STATE: CA ZIP: 90265 SC 13G/A 1 gtcb_sc13ga1-05092003.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1 ) GTC Biotherapeutics, Inc - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 36238T104 - -------------------------------------------------------------------------------- (CUSIP Number) May 6, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |X| Rule 13d-1(b) |_| Rule 13d-1(c) |_| Rule 13d-1(d) CUSIP NO. 36238T104 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON Intrinsic Value Asset Management, Inc 95-4779707 - -------------------------------------------------------------------------------- 2 CHECK APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION California - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 1,017,770 NUMBER OF -------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENFICIALLY OWNED BY NA EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 1,017,770 -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER NA - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENFICIALLY OWNED BY EACH REPORTING PERSON 1,017,770 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES |_| - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 3.6% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IA - -------------------------------------------------------------------------------- Item 1. a) Name of Issuer: GTC Biotherapeutics, Inc b) Address: 175 Crossing Boulevard, Suite 410 Framingham, MA 01702 Item 2. a) Name of Filer: Intrinsic Value Asset Management, Inc b) Address of Filer: 522 Wilshire Blvd. Suite D Santa Monica, California 90401 c) Citizenship: California d) Title of Class of Securities: Common Stock e) CUSIP Number: 36238T104 Item 3. Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) |_| Broker or Dealer registered under Section 15 of the Act (b) |_| Bank as defined in section 3 (a) (6) of the Act (c) |_| Insurance Company as defined in section 3 (a) (6) of the Act (d) |_| Investment Company registered under section 8 of the Investment Company Act (e) |X| Investment Adviser registered under section 203 of the Investment Advisers act of 1940 (f) |_| Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 240.13d-1 (b) (1) (ii) (F) (g) |_| Parent Holding Company, in accordance with 240.13d-1 (b) (ii) (G) (Note: See Item 7) (h) |_| Group, in accordance with 240.13d-1(b) (1) (ii) (H) Item 4. Ownership a) Amount beneficially owned: 1,017,770 b) Percent of Class: 3.6% c) Number of shares: (i) Sole voting power -- 1,017,770 (ii) Shared voting power -- na (iii) Sole disposal power -- 1,017,770 (iv) Shared disposal power - na Item 5. Less than 5% beneficial ownership If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x]. Item 6. More than 5% on behalf of another na Item 7. Subsidiary na Item 8. If group na Item 9. Notice of Dissolution na Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. May 09, 2003 Date Intrinsic Value Asset Management, Inc. By: /s/ Kenneth Luskin, President --------------------------------------- Name, Title -----END PRIVACY-ENHANCED MESSAGE-----